Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder by Lauren M. Schmitt, Elizabeth G. Smith, Ernest V. Pedapati, Paul S. Horn, Meredith Will, Martine Lamy, Lillian Barber, Joe Trebley, Kevin Meyer, Mark Heiman, Korbin H. J. West, Phoevos Hughes, Sanjeev Ahuja, Craig A. Erickson

Get full text